InvestorsHub Logo
Followers 113
Posts 11900
Boards Moderated 0
Alias Born 07/10/2014

Re: H2R post# 379375

Wednesday, 05/19/2021 1:25:50 PM

Wednesday, May 19, 2021 1:25:50 PM

Post# of 711812
And in fact to note is her slides are including DcVaxL as if it is SOC already; and she is gliding into combo research and everything trying to cure all genetic GBM patients irrespective of methylated or unmethylated. She knows the effectiveness of DcVaxL is almost the same irrespective of molecular profile of the patients, imo. In other words, everything she does in her research world revolves around DcVaxL. And I saw the Q&A today in her St Sinai presentation; look at the faces of those doctors lighting up when they ask her question, looking up to her, such a huge respect in this field; these things don't come for a failed trial she is running. We are just well blessed to have her do all the hard work. God Bless her!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News